Tofacitinib is an JAK3/2/1 Inhibitor for Chronic Inflammatory Disorders Research
JAK is a family of cytoplasmic tyrosine kinases consisting of four isoforms, JAK1, JAK2, JAK3 and TYK2. According to studies, JAKs transduce cytokine-mediated signals through the family of signal transducers…